Poly-ICLC (Hiltonol)

polyinosinic-polycytidylic acid stabilized with poly-L-lysine · Oncovir

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Poly-ICLC (Hiltonol), covering 2011-07-20 to 2015-12-08. Get the full timeline:

Most recent: Clinical Trial Update: HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas [EARLY_Phase 1]

See pricing